Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 9933 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1613 Views
-
Last post by NHE
-
- 0 Replies
- 1135 Views
-
Last post by NHE
-
- 0 Replies
- 1277 Views
-
Last post by NHE
-
- 4 Replies
- 1438 Views
-
Last post by NHE
-
- 0 Replies
- 1401 Views
-
Last post by NHE
-
- 0 Replies
- 1867 Views
-
Last post by frodo
-
- 0 Replies
- 1953 Views
-
Last post by NHE
-
- 0 Replies
- 1476 Views
-
Last post by NHE